CD8A and progressive multifocal leukoencephalopathy: CD8 T cells localize to demyelinating lesions in brains of PML patients, and PD-1 blockade and JCPyV-specific CD8 T cell adoptive immunotherapies have found success in treating this high morbidity/morality disease [7, 8].